https://edgen.beta.edgen.tech/ko/news/post/li-ning-slides-58-as-curry-deal-costs-raise-investor-concerns2026-06-03T03:46:06.299Zdaily1Edgen Stockko2026-06-03T03:46:06.299+00:00리닝, 커리 계약 비용 우려에 5.8% 하락https://static.edgen.tech/news/images/li-ning-slides-58-as-curry-deal-costs-raise-investor-concerns-20260603.png리닝, 커리 계약 비용 우려에 5.8% 하락 https://edgen.beta.edgen.tech/ko/news/post/china-capital-controls-create-hk43b-property-pipeline-from-mainland-buyers2026-06-03T03:44:22.123Zdaily1Edgen Stockko2026-06-03T03:44:22.123+00:00중국 자본통제, 본토 구매자 자금 430억 홍콩달러를 홍콩 주택 시장으로 유입시키다https://static.edgen.tech/news/images/china-capital-controls-create-hk43b-property-pipeline-from-mainland-buyers-20260603.png중국 자본통제, 본토 구매자 자금 430억 홍콩달러를 홍콩 주택 시장으로 유입시키다 https://edgen.beta.edgen.tech/ko/news/post/alphabet-slides-4-on-80b-ai-raise-as-copper-hits-record2026-06-03T03:24:30.703Zdaily1Edgen Stockko2026-06-03T03:24:30.703+00:00알파벳, 800억 달러 AI 자금 조달에 4% 하락…구리 사상 최고치https://static.edgen.tech/news/images/alphabet-slides-4-on-80b-ai-raise-as-copper-hits-record-20260603.png알파벳, 800억 달러 AI 자금 조달에 4% 하락…구리 사상 최고치 https://edgen.beta.edgen.tech/ko/news/post/australia-gdp-grows-03-in-q1-missing-estimates-on-weak-demand2026-06-03T03:10:54.804Zdaily1Edgen Stockko2026-06-03T03:10:54.804+00:00호주 1분기 GDP 0.3% 성장, 수요 부진으로 예상치 하회https://static.edgen.tech/news/images/australia-gdp-grows-03-in-q1-missing-estimates-on-weak-demand-20260603.png호주 1분기 GDP 0.3% 성장, 수요 부진으로 예상치 하회 https://edgen.beta.edgen.tech/ko/news/post/us-iran-clashes-push-oil-above-92-as-hormuz-reopening-stalls2026-06-03T03:09:04.808Zdaily1Edgen Stockko2026-06-03T03:09:04.808+00:00미·이란 충돌로 호르무즈 재개방 난항, 유가 92달러 돌파https://static.edgen.tech/news/images/us-iran-clashes-push-oil-above-92-as-hormuz-reopening-stalls-20260603.png미·이란 충돌로 호르무즈 재개방 난항, 유가 92달러 돌파 https://edgen.beta.edgen.tech/ko/news/post/innocares-mesutoclax-hits-100-response-rate-in-mds-trial-at-asco2026-06-03T03:08:51.445Zdaily1Edgen Stockko2026-06-03T03:08:51.445+00:00이노케어 메수토클락스, ASCO에서 MDS 임상시험 100% 반응률 달성https://static.edgen.tech/news/images/innocares-mesutoclax-hits-100-response-rate-in-mds-trial-at-asco-20260603.png이노케어 메수토클락스, ASCO에서 MDS 임상시험 100% 반응률 달성 https://edgen.beta.edgen.tech/ko/news/post/shake-shack-cuts-fy2026-guidance-by-up-to-9m-as-costs-pressure-margins2026-06-03T03:08:49.699Zdaily1Edgen Stockko2026-06-03T03:08:49.699+00:00셰이크쉑, 비용 압박으로 FY2026 가이던스 최대 900만 달러 하향 조정https://static.edgen.tech/news/images/shake-shack-cuts-fy2026-guidance-by-up-to-9m-as-costs-pressure-margins-20260603.png셰이크쉑, 비용 압박으로 FY2026 가이던스 최대 900만 달러 하향 조정 https://edgen.beta.edgen.tech/ko/news/post/goldman-ceo-says-markets-in-greed-mode-as-ai-giants-seek-80b2026-06-03T02:58:41.248Zdaily1Edgen Stockko2026-06-03T02:58:41.248+00:00골드만삭스 CEO "시장은 탐욕 모드"…AI 기업 800억 달러 자본 조달https://static.edgen.tech/news/images/goldman-ceo-says-markets-in-greed-mode-as-ai-giants-seek-80b-20260603.png골드만삭스 CEO "시장은 탐욕 모드"…AI 기업 800억 달러 자본 조달 https://edgen.beta.edgen.tech/ko/news/post/goldman-cuts-h-shares-to-equal-weight-lifts-a-share-target-to-55002026-06-03T02:58:35.988Zdaily1Edgen Stockko2026-06-03T02:58:35.988+00:00골드만, H주 비중 축소→중립, A주 목표치는 5,500으로 상향https://static.edgen.tech/news/images/goldman-cuts-h-shares-to-equal-weight-lifts-a-share-target-to-5500-20260603.png골드만, H주 비중 축소→중립, A주 목표치는 5,500으로 상향 https://edgen.beta.edgen.tech/ko/news/post/tencent-drops-32-as-wechat-ai-agent-launch-faces-regulatory-delays2026-06-03T02:38:40.875Zdaily1Edgen Stockko2026-06-03T02:38:40.875+00:00텐센트, 위챗 AI 에이전트 출시 규제 지연에 3.2% 하락https://static.edgen.tech/news/images/tencent-drops-32-as-wechat-ai-agent-launch-faces-regulatory-delays-20260603.png텐센트, 위챗 AI 에이전트 출시 규제 지연에 3.2% 하락 https://edgen.beta.edgen.tech/ko/news/post/morgan-stanley-lifts-yofc-target-5x-to-hkd230-on-ai-fibre-demand2026-06-03T02:36:32.730Zdaily1Edgen Stockko2026-06-03T02:36:32.730+00:00모건스탠리, AI 광섬유 수요에 YOFC 목표주가 5배 인상 HKD230으로https://static.edgen.tech/news/images/morgan-stanley-lifts-yofc-target-5x-to-hkd230-on-ai-fibre-demand-20260603.png모건스탠리, AI 광섬유 수요에 YOFC 목표주가 5배 인상 HKD230으로 https://edgen.beta.edgen.tech/ko/news/post/legend-biotechs-lb2501-posts-100-response-rate-in-lymphoma-trial2026-06-03T02:34:31.174Zdaily1Edgen Stockko2026-06-03T02:34:31.174+00:00레전드 바이오테크, LB2501 림프종 임상서 100% 반응률 기록https://static.edgen.tech/news/images/legend-biotechs-lb2501-posts-100-response-rate-in-lymphoma-trial-20260603.png레전드 바이오테크, LB2501 림프종 임상서 100% 반응률 기록 https://edgen.beta.edgen.tech/ko/news/post/hong-kong-tech-stocks-drop-2-as-meituan-falls-over-52026-06-03T02:22:31.673Zdaily1Edgen Stockko2026-06-03T02:22:31.673+00:00홍콩 기술주 2% 하락, 메이투안 5% 넘게 급락https://static.edgen.tech/news/images/hong-kong-tech-stocks-drop-2-as-meituan-falls-over-5-20260603.png홍콩 기술주 2% 하락, 메이투안 5% 넘게 급락 https://edgen.beta.edgen.tech/ko/news/post/goldman-sachs-and-citigroup-raise-japan-stock-targets-by-112026-06-03T02:19:48.852Zdaily1Edgen Stockko2026-06-03T02:19:48.852+00:00골드만삭스와 씨티그룹, 일본 주식 목표주가 11% 상향 조정https://static.edgen.tech/news/images/goldman-sachs-and-citigroup-raise-japan-stock-targets-by-11-20260603.png골드만삭스와 씨티그룹, 일본 주식 목표주가 11% 상향 조정 https://edgen.beta.edgen.tech/ko/news/post/lightmatter-joins-nvidia-nvlink-fusion-cutting-fiber-needs-by-502026-06-03T02:10:52.881Zdaily1Edgen Stockko2026-06-03T02:10:52.881+00:00Lightmatter, NVIDIA NVLink Fusion 합류…광섬유 필요량 50% 절감https://static.edgen.tech/news/images/lightmatter-joins-nvidia-nvlink-fusion-cutting-fiber-needs-by-50-20260603.pngLightmatter, NVIDIA NVLink Fusion 합류…광섬유 필요량 50% 절감 https://edgen.beta.edgen.tech/ko/news/post/applied-aerospace-defense-raises-650-million-in-us-ipo2026-06-03T02:10:17.201Zdaily1Edgen Stockko2026-06-03T02:10:17.201+00:00어플라이드 에어로스페이스 & 디펜스, 미국 IPO에서 6억 5천만 달러 조달https://static.edgen.tech/news/images/applied-aerospace-defense-raises-650-million-in-us-ipo-20260603.png어플라이드 에어로스페이스 & 디펜스, 미국 IPO에서 6억 5천만 달러 조달 https://edgen.beta.edgen.tech/ko/news/post/travere-pays-1125m-upfront-for-everests-kidney-disease-btk-drug2026-06-03T02:00:53.666Zdaily1Edgen Stockko2026-06-03T02:00:53.666+00:00Travere, 에베레스트의 신장질환 BTK 치료제에 선급금 1억 1250만 달러 지불https://static.edgen.tech/news/images/travere-pays-1125m-upfront-for-everests-kidney-disease-btk-drug-20260603.pngTravere, 에베레스트의 신장질환 BTK 치료제에 선급금 1억 1250만 달러 지불 https://edgen.beta.edgen.tech/ko/news/post/cspc-pharma-drops-34-as-china-approves-mrna-lnp-car-t-trial2026-06-03T01:59:37.228Zdaily1Edgen Stockko2026-06-03T01:59:37.228+00:00CSPC제약, 중국 mRNA-LNP CAR-T 임상 승인에 3.4% 하락https://static.edgen.tech/news/images/cspc-pharma-drops-34-as-china-approves-mrna-lnp-car-t-trial-20260603.pngCSPC제약, 중국 mRNA-LNP CAR-T 임상 승인에 3.4% 하락 https://edgen.beta.edgen.tech/ko/news/post/pateo-ping-an-capital-acquire-chip-firm-with-rmb310m-in-revenue2026-06-03T01:59:30.215Zdaily1Edgen Stockko2026-06-03T01:59:30.215+00:00PATEO, 핑안캐피털, 매출 3.1억 위안 통신칩 업체 인수https://static.edgen.tech/news/images/pateo-ping-an-capital-acquire-chip-firm-with-rmb310m-in-revenue-20260603.pngPATEO, 핑안캐피털, 매출 3.1억 위안 통신칩 업체 인수 https://edgen.beta.edgen.tech/ko/news/post/hang-seng-index-slides-1-as-middle-east-tensions-rattle-asian-markets2026-06-03T01:54:09.270Zdaily1Edgen Stockko2026-06-03T01:54:09.270+00:00홍콩 항셍지수, 중동 긴장 고조에 1% 하락…아시아 시장 흔들려https://static.edgen.tech/news/images/hang-seng-index-slides-1-as-middle-east-tensions-rattle-asian-markets-20260603.png홍콩 항셍지수, 중동 긴장 고조에 1% 하락…아시아 시장 흔들려